COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,436 Articles (22,835 medRxiv, 8,601 bioRxiv)

Most recent first Previous |  Page 382: Articles 3811-3820  | Next

Purification, crystallization, and preliminary structural analysis of multivalent immunogenic effector protein-anchored SARS-CoV-2 RBD
Kwon, T. H., Kim, T. G.
10.1101/2023.08.17.553661 — Posted: 2023-08-18
Virological characteristics of the SARS-CoV-2 XBB.1.5 variant
Tamura, T., Irie, T., Deguchi, S., Yajima, H., Tsuda, M., Nasser, H., Mizuma, K., Plianchaisuk, A., Suzuki, S., Uriu, K., Begum, M. M., Shimizu, R., Jonathan, M., Suzuki, R., Kondo, T., Ito, H., Kamiyama, A., Yoshimatsu, K., Shofa, M., Hashimoto, R., Anraku, Y., Kimura, K. T., Kita, S., Sasaki, J., Sasaki-Tabata, K., Maenaka, K., Nao, N., Wang, L., Oda, Y., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ikeda, T., Saito, A., Matsuno, K., Ito, J., Tanaka, S., Sato, K., Hashiguchi, T., Takayama, K., Fukuhara, T.
10.1101/2023.08.16.553332 — Posted: 2023-08-17
Assembly of SARS-CoV-2 ribonucleosomes by truncated N* variant of the nucleocapsid protein
Adly, A., Bi, M., Carlson, C., Syed, A. M., Ciling, A., Doudna, J., Cheng, Y., Morgan, D. O.
10.1101/2023.08.16.553581 — Posted: 2023-08-17
Molecular evolution and adaptation of SARS-CoV-2 omicron XBB sub-lineage Spike protein under African selection pressure.
Kambarami, M. S., Ngorima, G., Moyo, P. K., Mabaya, L., Mushiri, T., Manasa, J.
10.1101/2023.08.16.553557 — Posted: 2023-08-17
Mapping COVID-19 vaccine acceptance and uptake amongst Chinese residents: A systematic review and meta-analysis
Masood, H., Irfan, S. A.
10.1101/2023.08.09.23293915 — Posted: 2023-08-17
The CAPP 2 Study Protocol: Strengthening the capacity of healthcare providers to reduce the impact of COVID-19 on African, Caribbean, and Black communities in Ontario.
Etowa, J., Loemba, H., Bailey, L., Yaya, S., Dabone, C., Etowa, E., Ghose, B., Ajiboye, W., Tyerman, J., Luctkar-Flude, M., Rayner, J., Nnorom, O., Taylor, R., Beauchamp, S., Oneka, G., Kohoun, B., Tharao, W., Inoua, H., Edet, R., Kiirya, J., Allibhai, S., Kirunga, K., Kimei, J.
10.1101/2023.08.11.23293990 — Posted: 2023-08-16
Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients with and without history of SARS-CoV-2 infection
Bronder, S., Mihm, J., Urschel, R., Klemis, V., Schmidt, T., Marx, S., Abu-Omar, A., Hielscher, F., Guckelmus, C., Widera, M., Sester, U., Sester, M.
10.1101/2023.08.13.23294045 — Posted: 2023-08-16
Reproduction Number EXCEL Model of COVID-19 for predictive calculation of nearby trend up to the end of infection
Matsuda, S., Toki, H.
10.1101/2023.08.11.23293983 — Posted: 2023-08-16
Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetes
Gupta, J. K., Ravindrarajah, R., Tilston, G., Ollier, W., Ashcroft, D. M., Heald, A. H.
10.1101/2023.08.12.23294016 — Posted: 2023-08-16
Predicting subnational incidence of COVID-19 cases and deaths in EU countries
Robert, A., Chapman, L. A., Grah, R., Niehus, R., Sandmann, F. G., Prasse, B., Funk, S., Kucharski, A. J.
10.1101/2023.08.11.23293400 — Posted: 2023-08-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).